LEADER 02217nam  2200361   450 
001 9910734354903321
005 20230816070629.0
035   $a(CKB)5470000002907760
035   $a(NjHacI)995470000002907760
035   $a(EXLCZ)995470000002907760
100   $a20230816d2023      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aResearch of Pathogenesis and Novel Therapeutics in Arthritis 3.0 /$fedited by Chih-Hsin Tang
210  1$a[Place of publication not identified] :$cMDPI - Multidisciplinary Digital Publishing Institute,$d2023.
215   $a1 online resource (312 pages)
311   $a3-0365-8085-9 
330   $aArthritis has a high prevalence globally and includes over 100 types; the most common types are rheumatoid arthritis, osteoarthritis, psoriatic arthritis, and inflammatory arthritis. All types of arthritis share common features, including monocyte infiltration, inflammation, synovial swelling, pannus formation, stiffness in the joints, and articular cartilage destruction. The exact etiology of arthritis remains unclear, and no cure exists as of yet. Anti-inflammatory drugs (NSAIDs and corticosteroids) are commonly used for the treatment of arthritis. However, these drugs are associated with significant side effects, such as gastric bleeding and an increased risk of a heart attack and other cardiovascular problems. Therefore, it is crucial that we continue to research the pathogenesis of arthritis and novel modes of therapy. This reprint summarizes and discusses the themes of 19 articles published in our Special Issue "Research of Pathogenesis and Novel Therapeutics in Arthritis 3.0". The reprint details important novel research discoveries that contribute to our current understanding of arthritis.
606   $aTherapeutics
606   $aArthritis
615  0$aTherapeutics.
615  0$aArthritis.
676   $a616.722
702   $aTang$b Chih-Hsin
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910734354903321
996   $aResearch of Pathogenesis and Novel Therapeutics in Arthritis 3.0$93400929
997   $aUNINA